BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
80 hedge funds and large institutions have $115M invested in BRAINSTORM CELL THERAPUTC in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 14 closing their positions.
Holders
80
Holders Change
+4
Holders Change %
+5.26%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
27
Reduced
15
Closed
14
Calls
$17.6M
Puts
$37.8M
Net Calls
-$20.2M
Net Calls Change
+$8.77M
Top Buyers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$6.24M |
| 2 |
2
Northern Trust
Chicago,
Illinois
|
$5.37M |
| 3 |
3
SG Americas Securities
New York
|
$1.69M |
| 4 |
4
Voloridge Investment Management
Jupiter,
Florida
|
$1.45M |
| 5 |
5
First Trust Advisors
Wheaton,
Illinois
|
$1.09M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|
|
IC
102
Ikarian Capital
Dallas,
Texas
| – | – | – | – |
|
103
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|